Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT06342284
Official study title

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Study summary

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedProton Beam Radiation with or without concurrent chemotherapy

The study team can explain what participation involves.

Who it may be forThoracic Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 13, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?The New York Proton Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
The New York Proton Center
Interventions being studied
Radiation: Proton Beam Radiation with or without concurrent chemotherapy
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Chemotherapy→Radiation therapy→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
  • Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
  • Concurrent chemotherapy is permitted but not required..
  • Previous thoracic radiotherapy is allowed.
  • Ability to complete study surveys in English or Spanish
  • Age \>/= 18
  • Concurrent enrollment on other trials is permitted
  • Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period
  • All patients must sign study-specific informed consent prior to study entry
Reasons someone may not be able to joinExclusion criteria
  • Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
  • Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • New York Proton CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 13, 2026. Always confirm current availability with the study team.

View original record ↗